DEVON ENERGY CORP (DVN)

US25179M1036 - Common Stock

48.53  +1.75 (+3.74%)

Premarket: 49.68 +1.15 (+2.37%)


Fundamental Rating

6

Taking everything into account, DVN scores 6 out of 10 in our fundamental rating. DVN was compared to 378 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and the financial health of DVN get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on DVN.




Profitability

Profitability Rating

6

DVN has a Return On Assets of 25.50%. This is better than the industry average of 13.72%.
DVN has a Return On Equity of 54.40%. This is amongst the best returns in the industry. The industry average is 29.81%. DVN outperforms 82% of its industry peers.

DVN has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for DVN.
DVN's Profit Margin of 31.14% is in line with the rest of the industry. The industry average Profit Margin is 28.58%.
VS Industry

ROA (25.5%) VS Industry: 78% outperformed.

0.14
2,236.96

ROE (54.4%) VS Industry: 82% outperformed.

0.15
22,783.17

Profit Margin (31.14%) VS Industry: 54% outperformed.

0.19
159.88

Valuation

Valuation Rating

7

With a Price/Earnings Ratio of 6.15, the valuation of DVN can be described as very cheap.
The Forward Price/Earnings Ratio of 6.87 indicates a rather cheap valuation of DVN.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DVN's Price/Earning Ratio is in line with the industry average which is at 5.43.

With a price book ratio of 2.84, DVN is valued correctly.
Compared to an average industry Enterprise Value to EBITDA ratio of 3.64, DVN is valued in line with its industry peers.
Compared to an average industry price book ratio of 1.38, DVN is valued more expensive than its industry peers. 80% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (6.15) VS Industry: 43% outperformed.

153.00
0.01

Price/Book (2.84) VS Industry: 20% outperformed.

4,837.36
0.04

Enterprise Value/ EBITDA (3.58) VS Industry: 50% outperformed.

235.43
0.36

Growth

Growth Rating

5

DVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.39%, which is quite impressive.
The Earnings Per Share has been growing by 39.20% on average over the past 5 years. This is a very strong growth
DVN shows a strong growth in Revenue. In the last year, the Revenue has grown by 37.31%.
DVN shows a strong growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 24.14% yearly.

Based on estimates for the next 5 years, DVN will show a decrease in Earnings Per Share. The EPS will decrease by -6.57% on average per year.
The Revenue is expected to decrease by -6.30% on average over the next 5 years.
The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS39.2% 88.54% 59.39% -21.34% -7.77% -7.18% -6.57%
Revenue24.14% 45.52% 37.31% -15.82% -6.65% -6.3% N/A

Health

Health Rating

6

DVN has an Altman-Z score of 3.74. This indicates that DVN is financially healthy and little risk of bankruptcy at the moment.
When comparing the Altman-Z score to an average industry score of 2.12, DVN is in better financial health than the average industry peer.
The Piotroski-F score of DVN is 7.00. This is a strong score and indicates good health and profitability for DVN.
A Current Ratio of 1.09 indicates that DVN should not have too much problems paying its short term obligations.

The Current Ratio is in line with the industry averages, which is at 1.14.
DVN has a Quick Ratio of 1.02. This is a normal value and indicates that DVN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick Ratio is in line with the industry averages, which is at 0.98.
Compared to an average industry Debt to Equity Ratio of 0.24, DVN is more dependent on financing than its industry peers.
VS Industry

Debt/Equity (0.59) VS Industry: 27% outperformed.

13.98
0.00

Quick Ratio (1.02) VS Industry: 51% outperformed.

0.00
186.31

Current Ratio (1.09) VS Industry: 45% outperformed.

0.00
186.31

Altman-Z (3.74) VS Industry: 73% outperformed.

-509,914.51
307.34

Dividend

Dividend Rating

8

With a Yearly Dividend Yield of 9.64%, DVN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.68, DVN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.71, DVN pays a better dividend.
On average, the dividend of DVN grows each year by 84.16%, which is quite nice.

DVN has paid a dividend for at least 10 years, which is a reliable track record.
55.39% of the earnings are spent on dividend by DVN. This is a bit on the high side, but may be sustainable.
DVN's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
VS Industry

Dividend Yield (9.64%) VS Industry: 80% outperformed.

0.29
63.00

DEVON ENERGY CORP

NYSE:DVN (6/2/2023, 7:04:00 PM)

Premarket: 49.68 +1.15 (+2.37%)

48.53

+1.75 (+3.74%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-08 2023-05-08/amc
Earnings (Next)07-31 2023-07-31/amc
Inst Owners71.65%
Inst Owner Change-7.55%
Ins Owners0.58%
Ins Owner Change-2.9%
Market Cap31.14B
Analysts77.06
Price Target64.61 (33.13%)
Dividend
Industry RankSector Rank
Dividend Yield 9.64%
Dividend Growth(5Y)84.16%
DP55.39%
Div Incr Years5
Div Non Decr Years5
Ex-Date06-14 2023-06-14 (0.52)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.64%
Min EPS beat(2)-6.05%
Max EPS beat(2)4.76%
EPS beat(4)3
Avg EPS beat(4)2.01%
Min EPS beat(4)-6.05%
Max EPS beat(4)7.67%
Revenue beat(2)N/A
Avg Revenue beat(2)-5.89%
Min Revenue beat(2)-7.81%
Max Revenue beat(2)-3.97%
Revenue beat(4)2
Avg Revenue beat(4)3.28%
Min Revenue beat(4)-7.81%
Max Revenue beat(4)16.36%
PT rev (1m)-4.56%
PT rev (3m)-16.67%
EPS NQ rev (1m)-5.18%
EPS NQ rev (3m)-19.77%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.85%
Revenue NQ rev (1m)-6.54%
Revenue NQ rev (3m)-11.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-18.51%
Valuation
Industry RankSector Rank
PE 6.15
Fwd PE 6.87
P/S 1.62
P/FCF 11.29
P/OCF 3.72
P/B 2.84
P/tB 3.05
EV/EBITDA 3.58
EPS(TTM)7.89
EY16.26%
EPS(NY)7.07
Fwd EY14.57%
FCF(TTM)4.3
FCFY8.86%
OCF(TTM)13.04
OCFY26.88%
SpS29.89
BVpS17.11
TBVpS15.93
PEG (NY)N/A
PEG (5Y)0.16
Profitability
Industry RankSector Rank
ROA 25.5%
ROE 54.4%
ROIC 34.08%
ROICexc 35.62%
ROICexgc 37.04%
OM 41.51%
PM 31.14%
GM 56.03%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROICexcg growth 3Y183.67%
ROICexcg growth 5Y131.55%
ROICexc growth 3Y187.06%
ROICexc growth 5Y131.33%
OM growth 3Y142.4%
OM growth 5Y77.72%
PM growth 3YN/A
PM growth 5Y17.64%
GM growth 3Y-11.88%
GM growth 5Y-8.85%
F-Score7
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 2.42
Debt/EBITDA 0.65
Cap/Depr 238.91%
Profit Quality 46.18%
Current Ratio 1.09
Quick Ratio 1.02
Altman-Z 3.74
F-Score7
WACC8.72%
ROIC/WACC4.25
Cap/Depr(3y)137.62%
Cap/Depr(5y)143.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y59.39%
EPS 3Y88.54%
EPS 5Y39.2%
EPS growth Q2Q-22.34%
EPS Next Y-21.34%
EPS Next 2Y-7.77%
EPS Next 3Y-7.18%
EPS Next 5Y-6.57%
Revenue growth 1Y37.31%
Revenue growth 3Y45.52%
Revenue growth 5Y24.14%
Revenue growth Q2Q0.29%
Revenue Next Year-15.82%
Revenue Next 2Y-6.65%
Revenue Next 3Y-6.3%
Revenue Next 5YN/A
EBIT growth 1Y81.51%
EBIT growth 3Y252.75%
EBIT growth 5Y120.62%
EBIT Next Year4.36%
EBIT Next 3Y1.8%
EBIT Next 5Y0.03%
FCF growth 1Y770.03%
FCF growth 3Y196.98%
FCF growth 5Y22.17%
OCF growth 1Y440.7%
OCF growth 3Y60.3%
OCF growth 5Y24.01%
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA